76 related articles for article (PubMed ID: 25502777)
1. High-resolution genomic and expression profiling reveals 105 putative amplification target genes in pancreatic cancer.
Mahlamäki EH; Kauraniemi P; Monni O; Wolf M; Hautaniemi S; Kallioniemi A
Neoplasia; 2004; 6(5):432-9. PubMed ID: 15548351
[TBL] [Abstract][Full Text] [Related]
2. Tiling resolution array CGH and high density expression profiling of urothelial carcinomas delineate genomic amplicons and candidate target genes specific for advanced tumors.
Heidenblad M; Lindgren D; Jonson T; Liedberg F; Veerla S; Chebil G; Gudjonsson S; Borg A; Månsson W; Höglund M
BMC Med Genomics; 2008 Jan; 1():3. PubMed ID: 18237450
[TBL] [Abstract][Full Text] [Related]
3. Mesenchymal-like pancreatic cancer cells harbor specific genomic alterations more frequently than their epithelial-like counterparts.
Sinha A; Cherba D; Bartlam H; Lenkiewicz E; Evers L; Barrett MT; Haab BB
Mol Oncol; 2014 Oct; 8(7):1253-65. PubMed ID: 24837184
[TBL] [Abstract][Full Text] [Related]
4. APOBEC3B: pathological consequences of an innate immune DNA mutator.
Burns MB; Leonard B; Harris RS
Biomed J; 2015; 38(2):102-10. PubMed ID: 25566802
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus E6 triggers upregulation of the antiviral and cancer genomic DNA deaminase APOBEC3B.
Vieira VC; Leonard B; White EA; Starrett GJ; Temiz NA; Lorenz LD; Lee D; Soares MA; Lambert PF; Howley PM; Harris RS
mBio; 2014 Dec; 5(6):. PubMed ID: 25538195
[TBL] [Abstract][Full Text] [Related]
6. Copy Number Variations in Pancreatic Cancer: From Biological Significance to Clinical Utility.
Oketch DJA; Giulietti M; Piva F
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203561
[TBL] [Abstract][Full Text] [Related]
7. RNA Exosome Component EXOSC4 Amplified in Multiple Cancer Types Is Required for the Cancer Cell Survival.
Taniue K; Tanu T; Shimoura Y; Mitsutomi S; Han H; Kakisaka R; Ono Y; Tamamura N; Takahashi K; Wada Y; Mizukami Y; Akimitsu N
Int J Mol Sci; 2022 Jan; 23(1):. PubMed ID: 35008922
[TBL] [Abstract][Full Text] [Related]
8. Transcriptomic Analysis of Laser Capture Microdissected Tumors Reveals Cancer- and Stromal-Specific Molecular Subtypes of Pancreatic Ductal Adenocarcinoma.
Birnbaum DJ; Begg SKS; Finetti P; Vanderburg C; Kulkarni AS; Neyaz A; Hank T; Tai E; Deshpande V; Bertucci F; Birnbaum D; Lillemoe KD; Warshaw AL; Mino-Kenudson M; Fernandez-Del Castillo C; Ting DT; Liss AS
Clin Cancer Res; 2021 Apr; 27(8):2314-2325. PubMed ID: 33547202
[TBL] [Abstract][Full Text] [Related]
9. APOBEC: A molecular driver in cervical cancer pathogenesis.
Revathidevi S; Murugan AK; Nakaoka H; Inoue I; Munirajan AK
Cancer Lett; 2021 Jan; 496():104-116. PubMed ID: 33038491
[TBL] [Abstract][Full Text] [Related]
10. A pooled genome-wide association study identifies pancreatic cancer susceptibility loci on chromosome 19p12 and 19p13.3 in the full-Jewish population.
Streicher SA; Klein AP; Olson SH; Kurtz RC; Amundadottir LT; DeWan AT; Zhao H; Risch HA
Hum Genet; 2021 Feb; 140(2):309-319. PubMed ID: 32671597
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of long noncoding RNA
Li T; Wu D; Liu Q; Wang D; Chen J; Zhao H; Zhang L; Xie C; Zhu W; Chen Z; Zhou Y; Datta S; Qiu F; Yang L; Lu J
Ann Transl Med; 2020 May; 8(9):582. PubMed ID: 32566609
[TBL] [Abstract][Full Text] [Related]
12. Loss of profilin 2 contributes to enhanced epithelial-mesenchymal transition and metastasis of colorectal cancer.
Zhang H; Yang W; Yan J; Zhou K; Wan B; Shi P; Chen Y; He S; Li D
Int J Oncol; 2018 Sep; 53(3):1118-1128. PubMed ID: 30015842
[TBL] [Abstract][Full Text] [Related]
13. Phosphoinositide 3-Kinase Signaling Pathway in Pancreatic Ductal Adenocarcinoma Progression, Pathogenesis, and Therapeutics.
Murthy D; Attri KS; Singh PK
Front Physiol; 2018; 9():335. PubMed ID: 29670543
[TBL] [Abstract][Full Text] [Related]
14. Genomic Variations in Pancreatic Cancer and Potential Opportunities for Development of New Approaches for Diagnosis and Treatment.
Lu S; Ahmed T; Du P; Wang Y
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28587243
[TBL] [Abstract][Full Text] [Related]
15. The BAX gene as a candidate for negative autophagy-related genes regulator on mRNA levels in colorectal cancer.
Gil J; Ramsey D; Szmida E; Leszczynski P; Pawlowski P; Bebenek M; Sasiadek MM
Med Oncol; 2017 Feb; 34(2):16. PubMed ID: 28035578
[TBL] [Abstract][Full Text] [Related]
16. Weighted gene co-expression network analysis reveals key genes involved in pancreatic ductal adenocarcinoma development.
Giulietti M; Occhipinti G; Principato G; Piva F
Cell Oncol (Dordr); 2016 Aug; 39(4):379-88. PubMed ID: 27240826
[TBL] [Abstract][Full Text] [Related]
17. Role of the single deaminase domain APOBEC3A in virus restriction, retrotransposition, DNA damage and cancer.
Wang Y; Schmitt K; Guo K; Santiago ML; Stephens EB
J Gen Virol; 2016 Jan; 97(1):1-17. PubMed ID: 26489798
[TBL] [Abstract][Full Text] [Related]
18. High-mobility group A2 overexpression is an unfavorable prognostic biomarker for nasopharyngeal carcinoma patients.
Liu Z; Wu K; Yang Z; Wu A
Mol Cell Biochem; 2015 Nov; 409(1-2):155-62. PubMed ID: 26183485
[TBL] [Abstract][Full Text] [Related]
19. Identification of genomic alterations in pancreatic cancer using array-based comparative genomic hybridization.
Liang JW; Shi ZZ; Shen TY; Che X; Wang Z; Shi SS; Xu X; Cai Y; Zhao P; Wang CF; Zhou ZX; Wang MR
PLoS One; 2014; 9(12):e114616. PubMed ID: 25502777
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
